Methods of treating prostate cancer

The present application relates to treating and/or preventing prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer,...

Full description

Saved in:
Bibliographic Details
Main Authors HASKELL III, Royal J, MOORE, Marcia Dougan, WANG, Jing, CREW, Andrew P, SNYDER, Lawrence B
Format Patent
LanguageEnglish
Published 12.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application relates to treating and/or preventing prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph, isotopic derivative, or prodrug thereof, wherein R
Bibliography:Application Number: AU20200370150